サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：結核ワクチン市場2022-2028
市場調査レポート
商品コード
1215700

結核ワクチン市場2022-2028

Tuberculosis Vaccine Market 2022-2028
出版日: | 発行: Orion Market Research | ページ情報: 英文 | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
結核ワクチン市場2022-2028
出版日: 2023年01月14日
発行: Orion Market Research
ページ情報: 英文
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の結核ワクチン市場は、予測期間中に8.4%の大幅なCAGRで成長すると予測されています。いくつかの種類の研究がパイプラインにあり、それが市場の成長を大きく支えています。WHOの世界結核（TB）レポート2021によると、2021年8月に25の医薬品が薬剤感受性結核、MDR-TB、または結核感染症の治療のために第I、第II、または第III相試験中であることがわかりました。そのほか、2021年4月、EDCTPとアムステルダム国際保健開発研究所（AIGHD）は、結核ワクチンに関する仮想世界フォーラムにおいて、世界の結核ワクチンの研究開発ロードマップを発表しました。世界保健機関（WHO）との緊密な協力のもとで実施されました。

さらに、市場で活動するプレイヤーも、市場の成長に大きく貢献しています。例えば、2021年7月、バイオファブリとIAVIは、結核（TB）ワクチン候補のMTBVACの有効性試験に向けて提携していました。さらに、予防接種で発生する副作用や、ワクチンの政府承認にかかる時間は、市場の成長を阻害する可能性のある大きな要因となっています。ワクチン接種に関する意識の高まりと、ワクチン接種プログラムに対する政府の資金提供の増加は、予測期間中に市場に新たな成長機会をもたらす可能性があります。

結核ワクチン市場は、地域的には北米、欧州、アジア太平洋地域、その他の地域に区分されます。アジア太平洋地域は、本市場で最も速い成長を示すと思われます。インド、中国、インドネシア、フィリピン、パキスタンなどの国々は、結核の症例数が多くなっています。また、世界保健機関によると、これらの国々は2020年の結核による死亡者数の60％を占めています。さらに、結核の撲滅に向けた政府の洗練された医療政策や、より優れた医療インフラが、予測期間中に北米地域が市場での優位性を維持するための支えとなる可能性があります。

目次

第1章 レポート概要

  • 現在の産業分析と成長性の展望
  • 調査方法とツール
  • 市場内訳
    • セグメント別
    • 地域別内訳

第2章 市場概要とインサイト

  • 調査範囲
  • アナリストの洞察と現在の市場動向
    • 主な調査結果
    • レコメンデーション
    • まとめ

第3章 競合情勢

  • 主要企業の分析
    • 概要
    • 財務分析
    • SWOT分析
    • 最近の動向
  • 主要な戦略分析

第4章 市場の決定要因

  • 動機付け要因
  • 阻害要因
  • ビジネスチャンス

第5章 市場セグメンテーション

  • 結核ワクチンの世界市場：タイプ別
    • 免疫療法用ワクチン
    • ブースターワクチン
  • 結核ワクチンの世界市場：エンドユーザー別
    • 病院
    • 診療所
    • その他

第6章 地域別分析

  • 北米
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • イタリア
    • スペイン
    • フランス
    • その他欧州
  • アジア太平洋地域
    • 中国
    • インド
    • 日本
    • 韓国
    • その他アジア太平洋地域
  • 世界のその他の地域
    • ラテンアメリカ
    • 中東＆アフリカ

第7章 企業プロファイル

  • AJ Vaccines A/S
  • China National Pharmaceutical Group Corp
  • Dr. Reddy's Laboratories Ltd.
  • GlaxoSmithKline PLC
  • GreenSignal Bio Pharma Pvt. Ltd.
  • InterVax Ltd.
  • Japan BCG Laboratory
  • Merck & Co. Inc.
  • Novartis International AG
  • Pfizer Inc.
  • Sanofi SA
  • Serum Institute of India Ltd.
  • Statens Serum Institut
  • Taj Pharmaceuticals Ltd.
  • Torlak Institute of Virology.
図表

LIST OF TABLES

  • 1. GLOBAL TUBERCULOSIS VACCINE MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
  • 2. GLOBAL IMMUNOTHERAPEUTIC TUBERCULOSIS VACCINE MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 3. GLOBAL BOOSTER TUBERCULOSIS VACCINE MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 4. GLOBAL TUBERCULOSIS VACCINE MARKET RESEARCH AND ANALYSIS BY END-USER, 2021-2028 ($ MILLION)
  • 5. GLOBAL TUBERCULOSIS VACCINE IN HOSPITALS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 6. GLOBAL TUBERCULOSIS VACCINE IN CLINICS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 7. GLOBAL TUBERCULOSIS VACCINE IN OTHER END-USERS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 8. GLOBAL TUBERCULOSIS VACCINE MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 9. NORTH AMERICAN TUBERCULOSIS VACCINE MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
  • 10. NORTH AMERICAN TUBERCULOSIS VACCINE MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
  • 11. NORTH AMERICAN TUBERCULOSIS VACCINE MARKET RESEARCH AND ANALYSIS BY END-USER, 2021-2028 ($ MILLION)
  • 12. EUROPEAN TUBERCULOSIS VACCINE MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
  • 13. EUROPEAN TUBERCULOSIS VACCINE MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
  • 14. EUROPEAN TUBERCULOSIS VACCINE MARKET RESEARCH AND ANALYSIS BY END-USER, 2021-2028 ($ MILLION)
  • 15. ASIA-PACIFIC TUBERCULOSIS VACCINE MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
  • 16. ASIA-PACIFIC TUBERCULOSIS VACCINE MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
  • 17. ASIA-PACIFIC TUBERCULOSIS VACCINE MARKET RESEARCH AND ANALYSIS BY END-USER, 2021-2028 ($ MILLION)
  • 18. REST OF THE WORLD TUBERCULOSIS VACCINE MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
  • 19. REST OF THE WORLD TUBERCULOSIS VACCINE MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
  • 20. REST OF THE WORLD TUBERCULOSIS VACCINE MARKET RESEARCH AND ANALYSIS BY END-USER, 2021-2028 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL TUBERCULOSIS VACCINE MARKET SHARE BY TYPE, 2021 VS 2028 (%)
  • 2. GLOBAL TUBERCULOSIS VACCINE MARKET SHARE BY END-USER, 2021 VS 2028 (%)
  • 3. GLOBAL TUBERCULOSIS VACCINE MARKET SHARE BY REGION, 2021 VS 2028 (%)
  • 4. GLOBAL IMMUNOTHERAPEUTIC TUBERCULOSIS VACCINE MARKET SHARE BY REGION, 2021 VS 2028 (%)
  • 5. GLOBAL BOOSTER TUBERCULOSIS VACCINE MARKET SHARE BY REGION, 2021 VS 2028 (%)
  • 6. GLOBAL TUBERCULOSIS VACCINE IN HOSPITALS MARKET SHARE BY REGION, 2021 VS 2028 (%)
  • 7. GLOBAL TUBERCULOSIS VACCINE IN CLINICS MARKET SHARE BY REGION, 2021 VS 2028 (%)
  • 8. GLOBAL TUBERCULOSIS VACCINE IN OTHER END-USERS MARKET SHARE BY REGION, 2021 VS 2028 (%)
  • 9. US TUBERCULOSIS VACCINE MARKET SIZE, 2021-2028 ($ MILLION)
  • 10. CANADA TUBERCULOSIS VACCINE MARKET SIZE, 2021-2028 ($ MILLION)
  • 11. UK TUBERCULOSIS VACCINE MARKET SIZE, 2021-2028 ($ MILLION)
  • 12. FRANCE TUBERCULOSIS VACCINE MARKET SIZE, 2021-2028 ($ MILLION)
  • 13. GERMANY TUBERCULOSIS VACCINE MARKET SIZE, 2021-2028 ($ MILLION)
  • 14. ITALY TUBERCULOSIS VACCINE MARKET SIZE, 2021-2028 ($ MILLION)
  • 15. SPAIN TUBERCULOSIS VACCINE MARKET SIZE, 2021-2028 ($ MILLION)
  • 16. REST OF EUROPE TUBERCULOSIS VACCINE MARKET SIZE, 2021-2028 ($ MILLION)
  • 17. INDIA TUBERCULOSIS VACCINE MARKET SIZE, 2021-2028 ($ MILLION)
  • 18. CHINA TUBERCULOSIS VACCINE MARKET SIZE, 2021-2028 ($ MILLION)
  • 19. JAPAN TUBERCULOSIS VACCINE MARKET SIZE, 2021-2028 ($ MILLION)
  • 20. SOUTH KOREA TUBERCULOSIS VACCINE MARKET SIZE, 2021-2028 ($ MILLION)
  • 21. REST OF ASIA-PACIFIC TUBERCULOSIS VACCINE MARKET SIZE, 2021-2028 ($ MILLION)
  • 22. REST OF THE WORLD TUBERCULOSIS VACCINE MARKET SIZE, 2021-2028 ($ MILLION)
目次
Product Code: OMR2026756

Title:Global Tuberculosis Vaccine Market Size, Share and Trends Analysis Report, By Type (Immunotherapeutic Vaccine and Booster Vaccine), By Application (Hospitals, Clinics, and Others), Forecast Period (2022-2028).

The global tuberculosis vaccine market is anticipated to grow at a substantial CAGR of 8.4% during the forecast period. Several types of research are in pipeline which is significantly supporting the market growth. According to the WHO's global tuberculosis (TB) report 2021, 25 medicines were in Phase I, Phase II, or Phase III studies in August 2021 for the treatment of drug-susceptible TB, MDR-TB, or TB infection. Besides, in April 2021, EDCTP and the Amsterdam Institute for Global Health and Development (AIGHD) launched a global TB vaccine R&D roadmap at the Virtual Global Forum on TB Vaccines. The project was conducted in close collaboration with the World Health Organization.

In addition, the players operating in the market are also helping significantly in the growth of the market. For instance, in July 2021, Biofabri and IAVI had partnered for efficacy trials of tuberculosis (TB) vaccine candidate MTBVAC. Additionally, side effects occurring from the vaccinations and the government approval time for the vaccine are the major factors that may hinder the growth of the market. Increasing awareness about vaccination and growing government funding for vaccination programs may bring new growth opportunities to the market during the forecast period.

The global tuberculosis vaccine market is segmented based on type and application. Based on type, the market is bifurcated into immunotherapeutic vaccines and booster vaccines. Based on application, the market is further sub-categorized into hospitals, clinics, and others. The immunotherapeutic vaccines such as the immune BCG segment accounted for the highest share in the past and are also the fastest-growing segment during the forecast period.

Geographically tuberculosis vaccine market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. Asia Pacific region will show the fastest growth in this market. Countries such as India, China, Indonesia, the Philippines, and Pakistan have a high number of TB cases. And according to the World Health Organization, these countries accounted for 60% of the total TB deaths in 2020. Moreover, sophisticated healthcare government policies toward exterminating TB, and better healthcare infrastructure may support the North American region to maintain its dominance in the market during the forecast period.

The major market players in the global tuberculosis vaccine market include Pfizer Inc., Merck & Co. Inc., Dr. Reddy's Laboratories Ltd., Novartis International AG, Sanofi SA, GlaxoSmithKline PLC, Serum Institute of India Ltd., Taj Pharmaceuticals Ltd., among others. The market players are also contributing significantly to the growth of the market by the adoption of various strategies including mergers and acquisitions, geographical expansion, partnerships, collaborations, and new product launches, to stay competitive in the market.

Research Methodology

The market study of the global tuberculosis vaccine market is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to break down the market into various segments, and derive the total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macroeconomic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives as possible, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.

Secondary Sources Include:

  • Financial reports of companies involved in the market.
  • Whitepapers, research papers, and news blogs.
  • Company websites and their product catalog.

The report provides an in-depth analysis of the market size and intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation

  • Global tuberculosis Vaccine Market Research and Analysis by Type
  • Global tuberculosis Vaccine Market Research and Analysis by Application

The Report Covers:

  • Comprehensive research methodology of the global tuberculosis vaccine market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the global tuberculosis vaccine market.
  • Insights about market determinants that are stimulating the global tuberculosis vaccine market.
  • Detailed and extensive market segments with the regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.

Table of Contents

1. Report Summary

  • Current Industry Analysis and Growth Potential Outlook
  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Geography

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion

3. Competitive Landscape

  • 3.1. Key Company Analysis
    • 3.1.1. Overview
    • 3.1.2. Financial Analysis
    • 3.1.3. SWOT Analysis
    • 3.1.4. Recent Developments
  • 3.2. Key Strategy Analysis

4. Market Determinants

  • 4.1. Motivators
  • 4.2. Restraints
  • 4.3. Opportunities

5. Market Segmentation

  • 5.1. Global Tuberculosis Vaccine Market by Type
    • 5.1.1. Immunotherapeutic Vaccine
    • 5.1.2. Booster Vaccine
  • 5.2. Global Tuberculosis Vaccine Market by End-User
    • 5.2.1. Hospitals
    • 5.2.2. Clinics
    • 5.2.3. Others

6. Regional Analysis

  • 6.1. North America
    • 6.1.1. United States
    • 6.1.2. Canada
  • 6.2. Europe
    • 6.2.1. UK
    • 6.2.2. Germany
    • 6.2.3. Italy
    • 6.2.4. Spain
    • 6.2.5. France
    • 6.2.6. Rest of Europe
  • 6.3. Asia-Pacific
    • 6.3.1. China
    • 6.3.2. India
    • 6.3.3. Japan
    • 6.3.4. South Korea
    • 6.3.5. Rest of Asia-Pacific
  • 6.4. Rest of the World
    • 6.4.1. Latin America
    • 6.4.2. Middle East & Africa

7. Company Profiles

  • 7.1. AJ Vaccines A/S
  • 7.2. China National Pharmaceutical Group Corp
  • 7.3. Dr. Reddy's Laboratories Ltd.
  • 7.4. GlaxoSmithKline PLC
  • 7.5. GreenSignal Bio Pharma Pvt. Ltd.
  • 7.6. InterVax Ltd.
  • 7.7. Japan BCG Laboratory
  • 7.8. Merck & Co. Inc.
  • 7.9. Novartis International AG
  • 7.10. Pfizer Inc.
  • 7.11. Sanofi SA
  • 7.12. Serum Institute of India Ltd.
  • 7.13. Statens Serum Institut
  • 7.14. Taj Pharmaceuticals Ltd.
  • 7.15. Torlak Institute of Virology.